Focus type: computational_prediction
Prediction under review: GO-GPT (via BioReason-Pro) predicts lipid transfer activity (GO:0120013) for the Schizosaccharomyces pombe autophagy protein atg2 (UniProt O94649).
Verdict: SUPPORTED (with one specificity caveat).
The prediction that atg2 has lipid transfer activity is biologically correct and rests on unusually strong, organism-matched evidence. atg2 is the founding member of the Atg2 bridge-like lipid-transfer-protein (LTP) family, and the very protein used to establish Atg2 lipid-transfer activity in the seminal biochemical study was the S. pombe ortholog itself (Osawa et al. 2019, PMID 30911189). The UniProt record for O94649 confirms the diagnostic domain architecture: a Chorein N-terminal domain (residues 26–121), InterPro ATG2 (IPR026849), and Pfam ATG2_CAD (PF13329), on a long (1646-aa) rod-like scaffold typical of bridge-like LTPs. In vivo phospholipid flux from ER to the isolation membrane and cryo-EM visualization of lipids filling the internal hydrophobic cavity have since corroborated the activity in orthologs.
Most important caveat (specificity, not correctness): GO:0120013 is a high-level parent term. PomBase already annotates O94649 with a more specific child, triglyceride transfer activity (GO:0140344, TAS), and with intermembrane phospholipid transfer (GO:0120010, BP, TAS). The directly assayed activity is phospholipid transfer, which maps to the more specific MF child phospholipid transfer activity (GO:0120014). Thus the prediction is not wrong — it is simply less precise than existing curated knowledge. The seed's "lipid transfer vs. tethering/scaffold" dichotomy is a false binary: atg2 does both (it also carries EXP-supported protein-membrane adaptor activity, GO:0043495), with lipid transfer being the defining catalytic-like molecular function.
| Citation | Evidence type | Supports/Refutes | Claim tested | Key finding | Context | Confidence & limitations |
|---|---|---|---|---|---|---|
| Osawa et al. 2019 (PMID 30911189) | Direct in vitro assay + mutant phenotype | Supports | atg2 directly transfers phospholipids | S. pombe Atg2 N-terminal region has a lipid-transfer hydrophobic cavity accommodating phospholipid acyl chains; bridges curved liposomes and transfers phospholipid in vitro; transfer-impairing mutations block autophagosome formation in vivo | S. pombe Atg2, reconstituted liposomes | High. Exact target protein/organism. In vitro reconstitution. |
| UniProt/InterPro (O94649; IPR026849, PF13329, Chorein-N 26–121) | Structural/evolutionary (computational) | Supports | atg2 has Atg2-family LTP architecture | 1646-aa rod protein with Chorein N-terminal domain, ATG2 InterPro, ATG2_CAD Pfam, PANTHER PTHR13190 | Database record | High. Domain assignment is diagnostic of the bridge-like LTP fold. |
| AlphaFold AF-O94649-F1 (v6) | Structural (computational, this study) | Supports | atg2 forms an elongated bridge-like rod | End-to-end Cα distance 209 Å (~21 nm); anisotropy 12.5; Rg 63 Å; Chorein-N (26–121) pLDDT 78.8 | AlphaFold model, full 1646 aa | Medium-high. Predicted model (global pLDDT 59); rod length matches an ER–phagophore contact-site bridge. |
| McEwan & Ryan 2022 (PMID 34783437) | Review | Supports | Chorein-N ATG2 proteins are lipid transporters | ATG2/VPS13 Chorein-N proteins form molecular bridges transporting lipids ER→phagophore | Review synthesis | Medium (review-level orientation). |
| Hao et al. 2026 (PMID 41805856) | In vivo probe assay | Supports | Atg2 transfers phospholipid in vivo | R18 dye tracing shows phospholipid transfer from ER to isolation membrane via Atg2 during autophagy | Yeast, in vivo | High for pathway; ortholog (S. cerevisiae) context. |
| Ramirez et al. 2026 (PMID 42162239) | Structural (cryo-EM) + MD | Supports | Atg2 cavity holds/transfers lipids | Lipid densities fill Atg2's internal hydrophobic cavity along its full length; complex promotes lipid transfer into phagophore | Yeast Atg2–Atg18 | High for mechanism; ortholog context. |
| Zheng et al. 2025 (PMID 40128367) | Regulation/mechanism | Supports | ATG2 is a lipid transfer protein | ATG2A described as a rod-like LTP transporting phospholipids ER→phagophore; S-palmitoylation regulates it | Human ATG2A, cells | High for family activity; human ortholog. |
| PomBase/UniProt existing GO (GO:0140344 TAS; GO:0120010 TAS; GO:0043495 EXP) | Database/curation | Qualifies | Most-specific supported MF | atg2 already curated with triglyceride transfer activity + intermembrane phospholipid transfer + membrane-adaptor activity | Database | High. Shows prediction is redundant with a deeper child term. |
| Valverde et al. 2019 (PMID 30952800) | Direct in vitro assay + mutant | Supports (convergent) | ATG2 family transfers lipid | Human ATG2A binds tens of glycerophospholipids at once and transfers lipids robustly in vitro; N-terminal fragment is necessary and sufficient to rescue autophagosome biogenesis | Human ATG2A, in vitro/cells | High. Independent lab + ortholog, same conclusion, same year as PMID 30911189. |
| Ghanbarpour/Valverde et al. 2021 (PMID 33850023) | Model/mechanism | Qualifies | LTP + scramblase partnership | ATG2 (LTP) partners with scramblases TMEM41B/VMP1/ATG9 for membrane expansion | Model, in vitro assays | Medium. Frames tethering/scramblase roles as complementary, not competing. |
| Wang et al. 2001 (PMID 11382760) | Mutant phenotype | Qualifies (context) | Atg2 required for autophagy/Cvt/pexophagy | Atg2 is a peripheral membrane protein essential for sequestering-vesicle formation | S. cerevisiae | Medium; establishes membrane association, predates LTP model. |
Lead (requires curator verification):
Net: the prediction is a correct-but-generic lead. Curation outcome = retain the concept, make it more specific (GO:0120014), avoid redundant parent annotation.
Immediate molecular function tested: direct, non-vesicular transfer of phospholipid monomers between membrane bilayers via an elongated Chorein-N/VPS13-like hydrophobic groove. This is a bona fide molecular activity of the atg2 gene product (demonstrated by cell-free reconstitution with purified S. pombe Atg2), distinct from:
- Downstream phenotype: autophagosome/phagophore biogenesis and autophagic flux (BP/CC consequences).
- Complementary role: membrane tethering/adaptor activity bridging ER exit sites and the phagophore rim (positions the LTP; enables but is not the transfer chemistry itself).
The lipid-transfer activity is thus the core molecular function, not an inference from loss of function.
Computational checks run (see execute_code outputs): (1) UniProt O94649 domain/feature and existing-GO retrieval — confirmed Chorein-N domain (26–121), IPR026849, PF13329, and existing lipid-transfer-related GO annotations; (2) QuickGO ontology relationship check — confirmed GO:0120013 is an is_a ancestor of both GO:0140344 and GO:0120014; (3) AlphaFold model AF-O94649-F1 (v6) Cα geometry — end-to-end 209 Å, anisotropy 12.5, Chorein-N pLDDT 78.8, confirming an elongated bridge-like rod. No results were fabricated; all API calls returned live data.
Artifact files (in artifacts/): atg2_evidence_matrix.csv, atg2_GO_decision_table.csv, O94649_structural_metrics.csv.